Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 37,932	$ 9,123
General and administrative	22,511	4,377
Total operating expenses	60,443	13,500
Loss from operations	(60,443)	(13,500)
Other income (expense), net:
Other income, net	24
Related party convertible note interest expense		(40)
Change in fair value of the Series A redeemable convertible preferred stock tranche liability	(10,341)	(54,833)
Total other income (expense), net	(10,317)	(54,873)
Net loss and comprehensive loss	$ (70,760)	$ (68,373)
Net loss per share attributable to common stockholders—basic and diluted	$ (2.45)	$ (29.93)
Weighted-average shares used in computing net loss per share—basic and diluted	28,919,255	2,284,087